Elevance Health (ELV) Free Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Free Cash Flow data on file, last reported at $4.1 billion in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $4.1 billion, up 399.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 billion (up 75.56% YoY), and the FY2025 annual result was $3.2 billion, down 30.27% from the prior year.
• Free Cash Flow advanced to $4.1 billion in Q1 2026 per ELV's latest filing, from -$209.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $6.2 billion in Q1 2023 and troughed at -$3.3 billion in Q4 2023.
• A 5-year average of $1.5 billion and a median of $1.7 billion in 2024 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow sank 236.34% in 2022, then jumped 1341.13% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$1.8 billion in 2022, then plunged by 81.55% to -$3.3 billion in 2023, then soared by 111.65% to $384.0 million in 2024, then tumbled by 154.43% to -$209.0 million in 2025, then jumped by 2060.29% to $4.1 billion in 2026.
• Business Quant data shows ELV's Free Cash Flow at $4.1 billion in Q1 2026, -$209.0 million in Q4 2025, and $775.0 million in Q3 2025.